Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan

被引：0
|
作者：
Kyoko Ohno-Matsui
Makoto Suzaki
Rie Teshima
Nina Okami
机构：
[1] Tokyo Medical and Dental University,Department of Ophthalmology and Visual Science
[2] Novartis Pharma K.K.,Medical Scientific Expert, Medical Division
[3] Novartis Pharma K.K.,Biostatistics, Japan Development
[4] Novartis Pharma K.K.,Patient Safety Japan, Regulatory Office Japan
来源：
Eye | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1871 / 1878
页数：7
相关论文
共 50 条
  • [1] Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
    Ohno-Matsui, Kyoko
    Suzaki, Makoto
    Teshima, Rie
    Okami, Nina
    EYE, 2018, 32 (12) : 1871 - 1878
  • [2] Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
    Hamilton, Robin D.
    Clemens, Andreas
    Minnella, Angelo Maria
    Lai, Timothy Y. Y.
    Dai, Hong
    Sakamoto, Taiji
    Cheung, Chui Ming Gemmy
    Ngah, Nor Fariza
    Dunger-Baldauf, Cornelia
    Holz, Frank G.
    PLOS ONE, 2020, 15 (01):
  • [3] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [4] Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan
    Takei, Syuji
    Iwata, Naomi
    Kobayashi, Ichiro
    Igarashi, Toru
    Yoshinaga, Yoko
    Matsubara, Naoko
    Sunaga, Naomi
    Ito, Ayumi
    Yokota, Shumpei
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Clinical Profile of Suvorexant in a Real-World Setting: Results from a Post-Marketing Survey in Japan
    Sano, H.
    Asai, Y.
    Miyazaki, M.
    Iwakura, M.
    Maeda, M. Y.
    Hara, M. M.
    JOURNAL OF SLEEP RESEARCH, 2018, 27
  • [6] Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities
    Zhou, Cindy Ke
    Yasui, Daisaku
    Yoshinaga, Eiko
    Pearce, Kristina
    Martin, David
    Esposito, Daina B.
    Kubo, Tadamichi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 274 - 275
  • [7] Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
    Nakamura, Shiro
    Asano, Teita
    Tsuchiya, Hiroaki
    Sugimoto, Kanami
    Imai, Yuya
    Yokoyama, Seiji
    Suzuki, Yasuo
    INTESTINAL RESEARCH, 2022, 20 (03) : 329 - +
  • [8] The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan
    Takahashi, Makio
    Itou, Satoru
    Horiguchi, Shuji
    Tsuji, Yukie
    NEUROLOGY, 2022, 98 (18)
  • [9] Real-world effectiveness of eculizumab in generalized myasthenia gravis in Japan: 1-year post-marketing surveillance data
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Fukamizu, Yuji
    Osawa, Takehiko
    Kikui, Hidekazu
    Utsugisawa, Kimiaki
    NEUROLOGY, 2022, 98 (18)
  • [10] Real-world experience with eculizumab in Japanese patients with myasthenia gravis: Post-marketing surveillance data
    Takahashi, M.
    Masuda, M.
    Watanabe, M.
    Fukamizu, Y.
    Osawa, T.
    Kikui, H.
    Murai, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 574 - 574
12345